resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“The adjusted means showed that postintervention HbA1c was lower on resveratrol (35.8 ± 0.43 mmol/mol) compared with placebo (37.6 ± 0.44 mmol/mol).”
Quoted verbatim from No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.. - Study
- RCT
- Dose
- 150 mg/d
- Population
- Overweight men and women, BMI 27-35 kg/m2, aged 40-70 y; resveratrol versus placebo, postintervention ANCOVA-adjusted means
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.2020PMID:32492138Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Glycated haemoglobin (HbA1c)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PCZS5K0WBSQ7MGQPG20JSQ